Back to search
Papanicolaou Smear
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Papanicolaou Smear trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Papanicolaou Smear trials you may qualify forOvarian cancer is the leading cause of death among gynecological malignancies. No screening test is available for this tumor. Serous Tubal Intraepithelial Carci…
The purpose of the study is to find out if a self-administered (by the patient) Papanicolaou (Pap) smear is as accurate as a traditional Pap smear administered…
The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
The Pap test plays a crucial role in the early detection of cervical cancer. A pilot single-center randomized controlled trial applied the peak-end concept and…
The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrua…
This parallel-group randomized controlled trial was conducted between Aprıl 2025 and December 2025 at a Training and Research Hospital in Türkiye among women wh…
This randomized controlled pretest-posttest experimental study aims to evaluate the effect of virtual reality (VR) on pain and anxiety levels experienced during…
Women's anxiety about gynecological examinations causes them to skip examinations during this process. Research shows that women with high levels of anxiety are…